Christian Eckert has joined Curexsys GmbH, which is developing therapeutic exosomes, as chief operating officer. Dr Eckert was most recently with Juno Therapeutics, a unit of Bristol Myers Squibb Co, where he was responsible for GMP manufacturing and external collaborations. Prior to this, he led project management at Medigene AG. Dr Eckert studied biology and biochemistry at the University of Wuerzburg, and earned a PhD at Ludwig Maximilian University of Munich, both in Germany.
Curexsys GmbH announced the appointment on 20 October 2021.
Copyright 2021 Evernow Publishing Ltd